Program of the 8th AMR Conference

Here is a first glimpse of the conference sessions planned for 2024. More details and speaker names will be released in the next months.

Conference Day 1
Wednesday, 6 March 2024

Conference Day 2
Thursday, 7 March 2024

Conference Day 1

Wednesday, 6 March 2024

09:00 – 11:00

Pre-conference meeting

BEAM Alliance General Assembly

09:30 – 11:00

Pre-conference workshop

tbd

11:30 – 13:00

Opening plenary

How can we combat AMR globally?

13:00 – 14:00

Lunch break

14:00 – 15:30

Parallel sessions

Taking actions on pull incentives

Preclinical models to optimize translation to human

Vaccines to keep AMR at bay

16:00 – 17:30

Parallel sessions

Meaningful clinical trials: combining regulatory and clinical differentiation needs

Novel disruptive approaches to fight AMR

Roundtable: How to build bridges between human and animal health?

18:00 – 19:30

Start-up pitch

Conference Day 2

Thursday, 7 March 2024

08:30 – 09:30

Plenary session

A phage cocktail for breakfast?

10:00 – 11:30

Parallel sessions

Tuberculosis: new tools against an old enemy

New tricks to combat fungal infections

Making the case for investing in AMR R&D

11:30 – 13:00

Lunch break

13:00 – 14:30

Parallel sessions

Fast, reliable and cost-effective diagnostics

Push funding: a lifeline for R&D

Technology update

15:00 – 16:30

Parallel sessions

Leveraging the power of diagnostics in clinical practice

Greatest reach to the greatest need

The true value of antimicrobial products

17:00 – 18:00

Closing plenary

Future threats: Making the invisible visible

BEAM Alliance program committee

Marc Gitzinger

CEO, BioVersys AG & President, BEAM Alliance

Florence Séjourné

CEO, Aurobac Therapeutics & Treasurer, BEAM Alliance

Deepali Patel

Director of international policy, AMR Action Fund